Taking into consideration this dynamic nature of the degree of insulin resistance, a history of T2DM may be viewed as a proxy for a temporary exposure to increased insulin and IGF levels and thus promotion of cell growth, which could increase the risk of cancer [12]. The gene discussed is IGF1; the disease is cancer.